GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BICO Group AB (OSTO:BICO) » Definitions » Debt-to-EBITDA

BICO Group AB (OSTO:BICO) Debt-to-EBITDA : 40.95 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is BICO Group AB Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

BICO Group AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr118 Mil. BICO Group AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr1,864 Mil. BICO Group AB's annualized EBITDA for the quarter that ended in Mar. 2024 was kr48 Mil. BICO Group AB's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 40.95.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for BICO Group AB's Debt-to-EBITDA or its related term are showing as below:

OSTO:BICO' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -21.58   Med: 0.16   Max: 42.62
Current: -1.8

During the past 8 years, the highest Debt-to-EBITDA Ratio of BICO Group AB was 42.62. The lowest was -21.58. And the median was 0.16.

OSTO:BICO's Debt-to-EBITDA is ranked worse than
100% of 427 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs OSTO:BICO: -1.80

BICO Group AB Debt-to-EBITDA Historical Data

The historical data trend for BICO Group AB's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BICO Group AB Debt-to-EBITDA Chart

BICO Group AB Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial 0.08 -1.58 42.62 1.85 5.68

BICO Group AB Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.70 -0.82 5.39 -0.79 40.95

Competitive Comparison of BICO Group AB's Debt-to-EBITDA

For the Medical Devices subindustry, BICO Group AB's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BICO Group AB's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BICO Group AB's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where BICO Group AB's Debt-to-EBITDA falls into.



BICO Group AB Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

BICO Group AB's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(102.1 + 1856.2) / 345.1
=5.67

BICO Group AB's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(117.8 + 1864.1) / 48.4
=40.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


BICO Group AB  (OSTO:BICO) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


BICO Group AB Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of BICO Group AB's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


BICO Group AB (OSTO:BICO) Business Description

Traded in Other Exchanges
Address
Långfilsgatan 9, Gothenburg, SWE, 41277
BICO Group AB is a bio-convergence company. It is divided into three business areas: Bioprinting (CELLINK, MatTek, Visikol, and Nanoscribe), Biosciences (CYTENA, CYTENA Bioprocess Solutions, Dispendix, and Discover Echo), and Bioautomation (SCIENION, CELLENION, and Ginolis).

BICO Group AB (OSTO:BICO) Headlines

No Headlines